Updated PBAC Outcomes for March and July 2015

Outcomes for Nintedanib and Evolocumab from the March 2015 Pharmaceutical Benefits Advisory Committee (PBAC) meeting and Simeprevir and Nivolumab from the July 2015 PBAC meeting are now available.